The present invention concerns a pharmaceutical preparation for the treatment of Friedreich’s ataxia and for the treatment or prevention of pathologies related thereto. Particularly, the present invention concerns the use of diazoxide or 7-chloro-3-methyl-4H-1,2,4 benzothiadiazine 1,1-dioxide, in combination with glucose and/or leucine, for the treatment of Friedreich’s ataxia (FRDA) and for the treatment or prevention of pathologies related thereto.
Diazoxide for the treatment of Friedreich's ataxia
MAROBBIO, CARLO MARYA;
2010-01-01
Abstract
The present invention concerns a pharmaceutical preparation for the treatment of Friedreich’s ataxia and for the treatment or prevention of pathologies related thereto. Particularly, the present invention concerns the use of diazoxide or 7-chloro-3-methyl-4H-1,2,4 benzothiadiazine 1,1-dioxide, in combination with glucose and/or leucine, for the treatment of Friedreich’s ataxia (FRDA) and for the treatment or prevention of pathologies related thereto.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
